Arbutus to Present AB-729 and AB-836 Data at EASL Congress
WARMINSTER, Pa., June 07, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging...
Source: globenewswire.com
Abstracts Accepted News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Abstracts Accepted. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Abstracts Accepted Today - Breaking & Trending Today
Arbutus to Present AB-729 and AB-161 Data at the Global
Two oral presentations scheduled for Thursday, April 27, 2023 WARMINSTER, Pa., April 18, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:...
Source: globenewswire.com
Zymeworks Reports Fourth Quarter and Full Year 2022 Financial Results
2022 was a year of transformation and change:reported $412.5 million in total revenue for the year ended December 31, 2022;reported net income of $124.3 million ($1.90 per fully diluted share) for 2022 compared to net loss of $211.8 million in 2021;reported $492.2 million in cash resources as of December 31, 2022, w...
Source: pharmiweb.com